GO is the most frequent extrathyroidal manifestation of Graves' disease, although it may
rarely occur in euthyroid/hypothyroid patients with chronic autoimmune thyroiditis. It is a …

Graves orbitopathy, also known as thyroid eye disease or thyroid-associated orbitopathy, is
visually disabling, cosmetically disfiguring and has a substantial negative impact on a …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though
severe forms are rare. Management of GO is often suboptimal, largely because available …

Graves' orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal
manifestation of Graves' disease, the most common cause of hyperthyroidism. GO affects …

Current smoking in population surveys is associated with a slight dose‐dependent fall of
serum TSH, likely secondary to a rise of serum FT 4 and FT 3 induced by activation of the …

Methods European Group on GO (EUGOGO) represents a multidisciplinary consortium of
clinicians from the European centers, who share a commitment to improving the …

Graves' orbitopathy (GO) constitutes a major clinical and therapeutic challenge (1, 2). GO is
an autoimmune disorder representing the commonest and most important extrathyroidal …

Objective: The objective of this study was to examine whether TSH-receptor antibody [TSH
binding inhibitory antibodies (TBII)] levels are associated with the severity of Graves' …

Graves' disease (GD) is an autoimmune disease that primarily affects the thyroid gland. It is
the most common cause of hyperthyroidism and occurs at all ages but especially in women …